Comparison of Next Generation Diagnostic Systems (NGDS) for the Detection of SARS-CoV-2
Abstract
Over the last year, the COVID-19 pandemic has severely impacted lives of millions of US citizens, including active-duty service members and their beneficiaries. In response, the Department of Defense (DoD) began enterprise-wide testing at its medical centers, hospitals, and health clinics, which contributed and underscored the scarcity of collection and detection reagents throughout the country. Throughout the expansion of testing, it became apparent that there is need for specific and accurate detection of SARS-CoV-2 due to the overlap of its clinical symptoms with other respiratory pathogens, such as influenza and SARS-CoV-1.
Document Details
- Document Type
- Technical Report
- Publication Date
- Sep 29, 2021
- Accession Number
- AD1151887
Entities
People
- Anna R. Ochoa
- Antonio O. Sanchez
- August Blackburn
- Chet R. Voelker
- Jennifer S. McDaniel
- Rachel E. Mahoney
- Sallie L. Hall
- Susana N. Asin
- Tony T. Yuan
Organizations
- 59th Medical Wing